AcelRx

OPDP warns AcelRx over Dsuvia promotional materials
OPDP warns AcelRx over Dsuvia promotional materials
RAPS.org
FDA
OPDP
Dsuvia
AcelRx
warning letter
opioids
Flag link:
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
Flag link:
A Covid-19 threat to business acquisitions
A Covid-19 threat to business acquisitions
EP Vantage
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Flag link:
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
antibiotics
Tetraphase
M&A
AcelRx
Flag link:
Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines
Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines
BioSpace
Sarepta Therapeutics
AcelRx
stock offering
Flag link:
FDA to develop new framework for opioid analgesics following AcelRx approval
FDA to develop new framework for opioid analgesics following AcelRx approval
Drug Delivery Business News
FDA
opioids
Dsuvia
AcelRx
Flag link:
Despite criticism and concerns, FDA approves a new opioid 10 times more powerful than fentanyl
Despite criticism and concerns, FDA approves a new opioid 10 times more powerful than fentanyl
Stat
FDA
opioids
Dsuvia
AcelRx
Flag link:
AcelRx shares fall as Sen. Markey calls on FDA to reject opioid painkiller
AcelRx shares fall as Sen. Markey calls on FDA to reject opioid painkiller
Drug Delivery Business News
AcelRx
Dsuvia
FDA
opioids
Flag link:
3 Biotechs Awaiting FDA Approval Decisions
3 Biotechs Awaiting FDA Approval Decisions
Motley Fool
FDA
TherapeuticsMD
TX-001HR
AcelRx
Dsuvia
Loxo Oncology
larotrectinib
Flag link:
FDA panel votes in favor of AcelRx's pain candidate
FDA panel votes in favor of AcelRx's pain candidate
BioCentury
Dsuvia
ARX-04
FDA
AcelRx
Flag link:
AcelRx tackles acute pain with sublingual drug-delivery tech
AcelRx tackles acute pain with sublingual drug-delivery tech
Drug Delivery Business News
AcelRx
acute pain
drug delivery
sublingual treatments
Flag link:
FDA rejection blocks another AcelRx drug from US market
FDA rejection blocks another AcelRx drug from US market
Biopharma Dive
FDA
AcelRx
Dsuvia
Flag link:
In a new setback, FDA kicks back AcelRx’s application for pain med — shares tank again
In a new setback, FDA kicks back AcelRx’s application for pain med — shares tank again
Endpoints
FDA
AcelRx
Dsuvia
ARX-04
painkillers
Flag link:
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
Motley Fool
AcelRx
painkillers
Dsuvia
FDA
Flag link:
AcelRx’s pain relief drug-device combo succeeds in late-stage trial
AcelRx’s pain relief drug-device combo succeeds in late-stage trial
Drug Delivery Business News
AcelRx
Zalviso
devices
drug-device combos
Flag link:
5 Biotech Stocks With Major Catalysts in July
5 Biotech Stocks With Major Catalysts in July
Motley Fool
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Flag link:
AcelRx's opioid painkiller succeeds in key study
AcelRx's opioid painkiller succeeds in key study
Yahoo/Reuters
AcelRx
opioids
painkillers
clinical trials
Flag link:
AcelRx Pharma's pain drug succeeds in late-stage study
AcelRx Pharma's pain drug succeeds in late-stage study
Yahoo/Reuters
AcelRx
painkillers
ARX-04
Flag link:
7 Biotech Stocks Moving Off The UBS Healthcare Conference
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
Flag link:
FDA rejects AcelRx's request for meeting on pain drug device
FDA rejects AcelRx's request for meeting on pain drug device
Yahoo/Reuters
FDA
devices
AcelRx
Zalviso
Flag link:

Pages